Definition, Diagnostic Criteria & Classification
| Question | Answer |
|---|---|
| 1. Define Rickets and Osteomalacia. How do they differ? | - Rickets: A disease of the growing skeleton characterized by defective mineralization of both the cartilaginous growth plate (physis) and newly formed bone osteoid in the metaphysis, occurring only before epiphyseal fusion in children. - Osteomalacia: Defective mineralization of bone osteoid throughout the mature bone trabeculae and cortex, occurring after epiphyseal fusion in adolescents and adults (no growth plate involvement). |
| 2. Classify Rickets etiologically based on pathogenesis. | 1) Calciopenic Rickets (Calcium / Vitamin D Deficiency): - Nutritional Vitamin D deficiency (inadequate sunlight, vegan diet). - Malabsorption (Celiac disease, Cystic fibrosis, Biliary atresia). - Impaired 25-hydroxylation (Chronic Liver Disease). - Vitamin D Dependent Rickets Type 1 (VDDR-I): Inactivating mutation in CYP27B1 gene encoding renal 25(OH)D-1-alpha-hydroxylase. - Vitamin D Dependent Rickets Type 2 (VDDR-II): Inactivating mutation in the Vitamin D Receptor (VDR) gene. 2) Phosphopenic Rickets (Renal Phosphate Wasting): - X-linked Hypophosphatemic Rickets (XLH): Inactivating mutation in PHEX gene causing FGF23 excess. - Autosomal Dominant Hypophosphatemic Rickets (ADHR - FGF23 mutation). - Autosomal Recessive Hypophosphatemic Rickets (ARHR - DMP1, ENPP1). - Renal Tubular Acidosis (Distal Type 1 RTA). - Renal Fanconi Syndrome: Cystinosis, Wilson disease, Galactosemia, Tyrosinemia. |
| 3. What is the clinical and biochemical definition of "Refractory Rickets"? | Refractory Rickets is defined as rickets that fails to heal clinically, biochemically, and radiologically within 4 to 8 weeks after administering therapeutic doses of Vitamin D3 (e.g., two oral/IM stoss doses of $300,000\text{ to } 600,000\text{ IU}$, or $2000-5000\text{ IU/day}$ daily for 12 weeks) with adequate calcium intake. |
| 4. What are the classical radiological hallmarks of active Rickets on wrist AP X-ray? | 1) Widening of the Growth Plate: Distance between the radiopaque metaphysis and the epiphyseal ossification center is widened ($>1-2\text{ mm}$). 2) Cupping: Metaphyseal margin becomes concave/saucer-shaped due to mechanical stress. 3) Fraying (Brush-like border): Metaphyseal zone of provisional calcification loses its sharp demarcating line and appears frayed, ragged, and irregular. 4) Splaying (Flaring): Metaphyseal end expands laterally. 5) Osteopenia / Cortical Thinning: Generalized demineralization, coarse trabecular pattern, and subperiosteal resorption. |
| 5. VIVA TRAP: What is the earliest radiological sign of Healing in Rickets? | Appearance of the Line of Provisional Calcification: a crisp, dense, transverse radiopaque line across the metaphysis separated from the old shaft by a radiolucent zone, appearing within 10 to 14 days of starting effective Vitamin D or phosphate therapy. |
Pathophysiology & Complications
| Question | Answer |
|---|---|
| 6. Explain the biochemical cascade in Nutritional (Calciopenic) Rickets (Stages 1, 2, and 3). | - Stage 1 (Early Hypocalcemia): Low 25(OH)D causes reduced intestinal calcium absorption $\rightarrow$ Serum Calcium falls, Phosphorus normal, PTH begins to rise, ALP normal/mildly elevated. - Stage 2 (Secondary Hyperparathyroidism - The Classic Stage): High PTH mobilizes calcium from bone (via osteoclasts) and increases renal calcium reabsorption $\rightarrow$ Serum Calcium normalizes, but PTH causes massive renal phosphate wasting $\rightarrow$ Serum Phosphorus drops severely; ALP rises markedly; skeletal lesions become florid. - Stage 3 (Severe Decompensation): Bone calcium stores exhausted $\rightarrow$ Both Calcium and Phosphorus are severely low, PTH extremely high, ALP markedly elevated; clinical tetany and fractures occur. |
| 7. VIVA TRAP: Why is Serum Calcium normal in the majority of children presenting with florid nutritional rickets? | Because of the compensatory action of Secondary Hyperparathyroidism (Stage 2 Rickets). Hypocalcemia triggers parathyroid glands to secrete massive amounts of PTH. PTH acts on osteoclasts to dissolve bone and restore plasma calcium into the normal range ($8.8-10.2\text{ mg/dL}$), but at the catastrophic expense of renal phosphate wasting and worsening skeletal demineralization. |
| 8. What is the pathophysiology of X-Linked Hypophosphatemic Rickets (XLH)? | XLH is caused by loss-of-function mutations in the PHEX gene on chromosome Xp22.1. Inactivation of PHEX endopeptidase in osteocytes leads to pathological overproduction and accumulation of Fibroblast Growth Factor 23 (FGF23). Excess circulating FGF23 acts on renal proximal tubules to: 1) Downregulate sodium-phosphate cotransporters (NaPi-IIa and NaPi-IIc), causing massive urinary phosphate wasting (low TRP) and severe hypophosphatemia. 2) Suppress renal 25(OH)D-1-alpha-hydroxylase and stimulate 24-hydroxylase, resulting in inappropriately normal or low $1,25(\text{OH})_2\text{D}$ levels despite profound hypophosphatemia. |
| 9. VIVA TRAP: Why are tetany and convulsions common in Nutritional Rickets but virtually NEVER seen in XLH? | In Nutritional Rickets, primary calcium deficiency drives hypocalcemia, precipitating neuromuscular excitability (tetany, laryngospasm, seizures). In XLH, the defect is purely phosphopenic: serum calcium and parathyroid hormone (PTH) are normal, preventing symptomatic hypocalcemia. |
Guidelines & Management Protocols
| Question | Answer |
|---|---|
| 10. How do you differentiate Nutritional Rickets, XLH, VDDR-I, and VDDR-II on biochemical profile? | |
| Parameter | Nutritional Rickets |
| :--- | :--- |
| Serum Calcium | Normal or Low |
| Serum Phosphorus | Low |
| Serum ALP | Markedly High |
| Serum PTH | High (Secondary) |
| 25(OH)D | Low (< 20 ng/mL) |
| 1,25(OH)2D | Variable/Normal |
| Alopecia | Absent |
| 11. Detail the management of Nutritional Vitamin D Deficiency Rickets (Global Consensus Protocol). | - Stoss Therapy: Oral Vitamin D3 (Cholecalciferol) at 300,000 to 600,000 IU given as a single oral dose (or divided into 2-4 doses over 1-2 days). - Daily Alternative Regimen: Oral Vitamin D3 at $2000\text{ to } 6000\text{ IU/day}$ for 12 weeks. - Mandatory Calcium Co-Administration: Elemental calcium $500\text{ mg/day}$ (as calcium carbonate or phosphate syrup) for 8–12 weeks to prevent the "hungry bone syndrome" and tetany during rapid remineralization. - Maintenance: Follow with $400-600\text{ IU/day}$ daily maintenance for life. |
| 12. Detail the conventional medical therapy for X-Linked Hypophosphatemia (XLH). | 1) Oral Elemental Phosphorus: $40\text{ to } 60\text{ mg/kg/day}$ divided into 4 to 5 equal doses throughout the day (using Joulie's solution or effervescent tablets). 2) Active Vitamin D (Calcitriol): $20\text{ to } 40\text{ ng/kg/day}$ divided BID. Mandatory co-administration to prevent secondary hyperparathyroidism caused by oral phosphate. 3) Monitoring: Serial spot urine Calcium-to-Creatinine ratio every 3 months (maintain $<0.2\text{ mg/mg}$ to prevent hypercalciuria) and annual renal ultrasound to detect nephrocalcinosis. |
| 13. What is Burosumab and how has it revolutionized XLH management? | Burosumab is a fully human monoclonal IgG1 antibody that directly targets and binds circulating FGF23, neutralizing its biological activity. Administered at $0.8\text{ mg/kg}$ subcutaneously every 2 weeks. It restores renal tubular phosphate reabsorption, normalizes serum phosphorus, heals rickets, improves linear growth velocity, and completely avoids the gastrointestinal side effects and nephrocalcinosis risk associated with oral phosphate therapy. |
VIVA TRAPs & Counter-Questions
| Question | Answer |
|---|---|
| 14. VIVA TRAP: A 1-year-old child presents with bowed legs and wrist widening. The serum ALP is 18 IU/L (severely low). What is your diagnosis? Can you give Vitamin D? | Diagnosis: Hypophosphatasia (rare inborn error of metabolism caused by ALPL gene mutations encoding Tissue-Nonspecific Alkaline Phosphatase / TNSALP). VIVA TRAP Warning: NEVER GIVE VITAMIN D! Giving Vitamin D will cause catastrophic hypercalcemia, hypercalciuria, nephrocalcinosis, and renal failure. Treatment is enzyme replacement therapy with Asfotase alfa. |
| 15. Counter-Question Chain: "A 2-year-old child with refractory rickets has low calcium, low phosphorus, high ALP, normal anion gap metabolic acidosis, and inability to acidify urine below pH 6.0. What is the diagnosis and treatment?" | 1) Diagnosis: Distal (Type 1) Renal Tubular Acidosis (dRTA) with Secondary Calciopenic Rickets. 2) Mechanism: Defective $H^+$ ion secretion by intercalated cells of distal nephron causes systemic metabolic acidosis; chronic acidosis buffers acid via bone dissolution and suppresses proximal tubular calcium reabsorption, causing severe hypercalciuria, rickets, and nephrocalcinosis. 3) Treatment: Alkali Therapy (Sodium/Potassium Citrate or Bicarbonate) at $2\text{ to } 5\text{ mEq/kg/day}$ in divided doses to correct acidosis. Once acidosis is corrected, rickets heals without requiring massive Vitamin D doses! |